Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan

被引:16
|
作者
Saghari, Mohsen [1 ]
Gholamrezanezhad, Ali [1 ]
Mirpour, Sahar [1 ]
Eftekhari, Mohammad [1 ]
Takavar, Abbas [1 ]
Fard-Esfahani, Armaghan [1 ]
Fallahi, Babak [1 ]
Beiki, Davood [1 ]
机构
[1] Univ Tehran, Res Inst Nucl Med, Tehran 14114, Iran
关键词
differentiated thyroid carcinoma; thyroglobulin; whole-body scanning;
D O I
10.1097/00006231-200607000-00004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction In the management of patients with differentiated thyroid carcinoma, serum thyroglobulin levels are often well correlated with whole-body radioiodine scanning (WBS) results. However, occasionally, a mismatched result - increased thyroglobulin with negative WBS - is observed. Radioiodine therapy has been suggested as a therapeutic choice with controversial results. Method We studied 32 differentiated thyroid carcinoma patients with elevated thyroglobulin level and negative WBS who had been treated with high-dose radioiodine. With a mean follow-up of 25.6 months (all follow-ups > 11 months), thyroglobulin and thyroid-stimulating hormone levels, WBS, clinical, radiographic and pathological findings following treatment were recorded. Results The mean pre-therapy off-treatment thyroglobulin was 152 +/- 119.0 ng (.) ml(-1). Although there was a mild trend towards an increase in thyroglobulin in the first post-treatment year, the difference was not significant. At the end of the follow-ups, 22 patients (68.7%) were categorized as non-responders to radioiodine therapy (any change or elevation of thyroglobulin or radiological and pathological evidences of progression), four patients (12.5%) as partial responders (transient reduction but not a normalization of thyroglobulin) and six patients (18.7%) as responders (normalization of thyroglobulin with no evidence of remnant disease). In nine of 10 partial and complete responders, reduction or normalization of thyroglobulin had occurred in the first post-treatment year. Conclusion We recommend that in differentiated thyroid carcinoma patients with elevated thyroglobulin and negative WBS, at least one course of radioiodine therapy should be undertaken and if reduction or normalization of serum thyroglobulin is not achieved, repeated courses of radioiodine therapy are not logical and other therapeutic methods should be applied.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 50 条
  • [1] Impact of aditional radioiodine treatment in well differentiated thyroid carcinoma in patients with negative whole-body scan and high thyroglobulin level
    Rocha, C.
    Vieira, F.
    Costa, G.
    Albuquerque, A.
    Freitas, D.
    Silva, F.
    Ferrer-Antunes, A.
    de Lima, J. Pedroso
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S330 - S330
  • [2] Undetectable Thyroglobulin in Patients With Differentiated Thyroid Carcinoma and Residual Radioiodine Uptake on a Postablation Whole-Body Scan
    Giovanella, Luca
    Suriano, Sergio
    Ceriani, Luca
    Verburg, Frederik Anton
    CLINICAL NUCLEAR MEDICINE, 2011, 36 (02) : 109 - 112
  • [3] Evaluation of iodine-131 therapy for differentiated thyroid carcinoma patients with elevated thyroglobulin and negative iodine-131 whole body scan.
    Tian, R
    Qin, SW
    Kuang, RA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 334P - 334P
  • [4] The Correlation of Radioiodine Whole Body Scan and Stimulated Thyroglobulin in Patients with Differentiated Thyroid Carcinoma
    Vlajkovic, M.
    Matovic, M.
    Rajic, M.
    Ilic, S.
    Stevic, M.
    Karanikolic, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S351 - S351
  • [5] Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases
    Filesi, M
    Signore, A
    Ventroni, G
    Melacrinis, FF
    Ronga, G
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (09) : 1542 - 1546
  • [6] Characteristics and prognosis of patients with thyroglobulin-positive and radioactive iodine whole-body scan-negative differentiated thyroid carcinoma
    Shinohara, Shogo
    Kikuchi, Masahiro
    Suehiro, Atsushi
    Kishimoto, Ippei
    Harada, Hiroyuki
    Hino, Megumu
    Ishihara, Takashi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (05) : 427 - 432
  • [7] The usefulness of fluorine-18 fluorodeoxyglucose PET in the detection of recurrence in patients with differentiated thyroid cancer with elevated thyroglobulin and negative radioiodine whole-body scan
    Stangierski, Adam
    Kaznowski, Jaroslaw
    Wolinski, Kosma
    Jodlowska, Elzbieta
    Michaliszyn, Piotr
    Kubiak, Katarzyna
    Czepczynski, Rafal
    Ruchala, Marek
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (09) : 935 - 938
  • [8] Management of Differentiated Thyroid Cancer with Rising Thyroglobulin and Negative Diagnostic Radioiodine Whole Body Scan
    Chao, M.
    CLINICAL ONCOLOGY, 2010, 22 (06) : 438 - 447
  • [9] Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases
    Ma, Chao
    Kuang, Anren
    Xie, Jiawei
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [10] SERUM THYROGLOBULIN AND WHOLE-BODY SCAN AS MARKERS IN THE FOLLOW-UP OF DIFFERENTIATED THYROID-CARCINOMA
    DEGROSSI, OJ
    ROZADOS, IB
    DAMILANO, S
    DEGROSSI, EB
    DEGANINO, L
    PINKAS, M
    DELRIO, HG
    ARTAGAVEYTIA, D
    MEDICINA-BUENOS AIRES, 1991, 51 (04) : 291 - 295